Insider Transactions in Q1 2021 at Instil Bio, Inc. (TIL)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 23
2021
|
Bronson Crouch CEO and Chairman |
BUY
Open market or private purchase
|
Indirect |
450,000
+1.17%
|
$9,000,000
$20.0 P/Share
|
Mar 23
2021
|
Bronson Crouch CEO and Chairman |
BUY
Conversion of derivative security
|
Indirect |
37,530,073
+22.71%
|
-
|
Mar 23
2021
|
R Kent Mc Gaughy Jr Director |
BUY
Open market or private purchase
|
Indirect |
450,000
+5.04%
|
$9,000,000
$20.0 P/Share
|
Mar 23
2021
|
R Kent Mc Gaughy Jr Director |
BUY
Conversion of derivative security
|
Indirect |
8,028,790
+30.31%
|
-
|
Mar 23
2021
|
Jack Nielsen Director |
BUY
Open market or private purchase
|
Indirect |
300,000
+2.35%
|
$6,000,000
$20.0 P/Share
|
Mar 23
2021
|
Jack Nielsen Director |
BUY
Conversion of derivative security
|
Indirect |
12,186,787
+26.88%
|
-
|
Mar 23
2021
|
Nimish P Shah Director |
BUY
Open market or private purchase
|
Indirect |
300,000
+24.0%
|
$6,000,000
$20.0 P/Share
|
Mar 23
2021
|
Nimish P Shah Director |
BUY
Conversion of derivative security
|
Indirect |
6,565,076
+32.89%
|
-
|
Mar 23
2021
|
Vivo Capital Ix, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
300,000
+2.35%
|
$6,000,000
$20.0 P/Share
|
Mar 23
2021
|
Vivo Capital Ix, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
12,186,787
+26.88%
|
-
|
Mar 23
2021
|
Curative Ventures V LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
450,000
+1.17%
|
$9,000,000
$20.0 P/Share
|
Mar 23
2021
|
Curative Ventures V LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
37,530,073
+22.71%
|
-
|